Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

the first hospital of Jilin University, Changchun, Jilin, China
Contact: Study coordinator (Pengyu Chang) · changpengyu@jlu.edu.cn · +86-18686653882

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer

Rectal Cancer · Total Neoadjuvant Therapy · Radiotherapy

Abroad (travel likely)RecruitingPHASE3

Wuhan, China

A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients

Colorectal Cancer

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

Colorectal Cancer

Abroad (travel likely)RecruitingPHASE3

Amberg, Germany · Bad Saarow, Germany

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

Malignancy · Malignant Neoplasm · Lymphoproliferative Disorders

Abroad (travel likely)RecruitingPHASE2, PHASE3

Belfast, United Kingdom · Birmingham, United Kingdom